Category1 Category2 Category3

The lab equipment makerâ€™s $5.2 billion acquisition of Patheon provides it with an avenue for growth but limited opportunities to cut costs.

ID:https://www.nytimes.com/2017/05/15/business/dealbook/thermo-fisher-tests-a-deal-in-drug-production.html_0